Supplementary
Values represent means ± SEM (n = 31). P values refer to two-tailed, paired t tests. Significant differences between conditions are highlighted in bold.
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Supplementary Figure S1
Example spectra depicting the signal detected for each resonance frequency (represented by the chemical shift in ppm). Representative spectra from the PRESS and MEGAPRESS sequences are shown in the left and right panels, respectively. Each spectrum is plotted in black with the LCModel fit overlaid in red. The residuals of the fit are also plotted above each spectrum.
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Supplementary Figure S2
Effects of sleep deprivation and recovery sleep on circulating blood brain derived neurotrophic factor (BDNF)protein levels. Columns display blood BDNF levels in baseline (BL, dark grey), sleep deprivation (TSD, red) and recovery (RE, light grey) conditions. Data represent means + standard error of the mean (SEM) in n = 31. Black dots represent individual subjects. Mixed model ANOVA main effect of 'condition': F2,90 = 0.23, p > 0.7. Results of mixed-model repeated-measures ANOVA with within-subject factor 'condition'
Supplementary
(BL, TSD, RE). Significant p-values are highlighted in bold. FMRP: fragile-x mental retardation protein; BDNF: brain-derived neurotrophic factor; PET: positron emission 6 tomography; MRS: magnetic resonance spectroscopy. dlPFC: dorsolateral prefrontal cortex;
GLX: glutamate-to-glutamine ratio; GABA: γ-aminobutyric acid; NAA: N-acetyl-aspartate; Supplementary Table S3 : Post-hoc comparisons of blood protein levels, PET and MRS variables to localize differences between conditions. FMRP: fragile-x mental retardation protein; BDNF: brain-derived neurotrophic factor; PET: positron emission tomography; MRS: magnetic resonance spectroscopy; DF: degrees of freedom; BL: baseline; TSD: total sleep deprivation; RE: recovery; dlPFC: dorsolateral prefrontal cortex;
Variable Region-of-interest
GLX: glutamate-to-glutamine ratio; GABA: γ-aminobutyric acid; NAA: N-acetyl-aspartate. Significant p-values are highlighted in bold.
